Aluminoparaaminosalicylate calcium hydrate

对氨基水杨酸铝钙水合物

Report date: 2024/06/27 17:00:26
NME

Base Information

Drug NameAluminoparaaminosalicylate calcium hydrate
Drug Alias NameAluminoparaaminosalicylate calcium pentahydrateAlumino nippas calcium
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFolate inhibitors
TargetsFolate
Therapy Area/IndicationsTuberculosis, PulmonaryTuberculosis
Global Approved IndicationsTuberculosis, PulmonaryTuberculosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1956/10/19
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Tanabe Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesMitsubishi Tanabe Pharma
Inactive CompaniesN/A
Active IndicationsTuberculosis, PulmonaryTuberculosis
Inactive IndicationsN/A

Other Information

ATC CodeJ04A
Related LinksKEGG